DYN Dyne Therapeutics (DYN) Q4 Loss Narrows to $0.73/Share vs $0.76 Estimate, Shares Surge 11.8% 7 days ago Dyne Therapeutics narrows Q4 loss to $0.73/share vs $0.76 estimate, shares jump 11.8% on improving trajectory and $893M cash position. Dyne Therapeutics (DYN) Q4 Loss Narrows to $0.73/Share vs $0.76 Estimate; Shares Surge 19% 1 week ago Dyne Therapeutics narrows Q4 loss to $0.73/share vs $0.76 estimate; shares jump 19% as clinical-stage biotech shows sequential improvement.